Abstract:Calcineurin is a calcium/calmodulin-regulated phosphatase known for its role in activation of T cells following engagement of the T cell receptor. Calcineurin inhibitors (CNIs) are widely used as immunosuppressive agents; common adverse effects of CNIs are hypertension and hyperkalemia. While previous studies have implicated activation of the Na-Cl cotransporter (NCC) in the renal distal convoluted tubule (DCT) in this toxicity, the molecular mechanism of this effect is unknown. The renal effects of CNIs mimic the hypertension and hyperkalemia that result from germ-line mutations in with-no-lysine (WNK) kinases and the Kelch-like 3 (KLHL3)-CUL3 ubiquitin ligase complex. WNK4 is an activator of NCC and is degraded by binding to KLHL3 followed by WNK4's ubiquitylation and proteasomal degradation. This binding is prevented by phosphorylation of KLHL3 at serine 433 (KLHL3S433-P) via protein kinase C, resulting in increased WNK4 levels and increased NCC activity. Mechanisms mediating KLHL3S433-P dephosphorylation have heretofore been unknown. We now demonstrate that calcineurin expressed in DCT is a potent KLHL3S433-P phosphatase. In mammalian cells, the calcium ionophore ionomycin, a calcineurin activator, reduces KLHL3S433-P levels, and this effect is reversed by the calcineurin inhibitor tacrolimus and by siRNA-mediated knockdown of calcineurin. In vivo, tacrolimus increases levels of KLHL3S433-P, resulting in increased levels of WNK4, phosphorylated SPAK, and NCC. Moreover, tacrolimus attenuates KLHL3-mediated WNK4 ubiquitylation and degradation, while this effect is absent in KLHL3 with S433A substitution. Additionally, increased extracellular K+ induced calcineurin-dependent dephosphorylation of KLHL3S433-P These findings demonstrate that KLHL3S433-P is a calcineurin substrate and implicate increased KLHL3 phosphorylation in tacrolimus-induced pathologies.

A novel motif in calcimembrin/C16orf74 dictates multimeric dephosphorylation by calcineurin

Crystallization Characteristics Of Calmodulin In Complex And Fused With Calcineurin Peptide

UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates

Preparation and Characterization of A Single-Chain Calcineurin-Calmodulin Complex

The Secondary Structure of Calcineurin Regulatory Region and Conformational Change Induced by Calcium/Calmodulin Binding*

Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode.

Structural Basis of Calcineurin Activation by Calmodulin

The Polarity of the Amino Acid Residue 118 of Calcineurin B is Closely Linked to Calcineurin Enzyme Activity

Cooperative autoinhibition and multi-level activation mechanisms of calcineurin

Calcineurin Dephosphorylates Kelch-like 3, Reversing Phosphorylation by Angiotensin II and Regulating Renal Electrolyte Handling.

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation Via Distinct Structural Degrons.

CRL4 Antagonizes SCFFbxo7-mediated Turnover of Cereblon and BK Channel to Regulate Learning and Memory

A novel non-canonical mechanism of regulation of MST3 (mammalian Sterile20-related kinase 3)

The role of loop 7 in mediating calcineurin regulation

Molecular glue CELMoD compounds are regulators of cereblon conformation

Cdc14 phosphatases use an intramolecular pseudosubstrate motif to stimulate and regulate catalysis

Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1

Function and Structure of N-terminal and C-terminal Domains of Calcineurin B Subunit.

Calcium modulates the tethering of BCOR-PRC1.1 enzymatic core to KDM2B via liquid-liquid phase separation

Function and structure of recombinant single chain calcineurin.